Literature DB >> 22985415

7-methylguanosine diphosphate (m(7)GDP) is not hydrolyzed but strongly bound by decapping scavenger (DcpS) enzymes and potently inhibits their activity.

Anna Wypijewska1, Elzbieta Bojarska, Maciej Lukaszewicz, Janusz Stepinski, Jacek Jemielity, Richard E Davis, Edward Darzynkiewicz.   

Abstract

Decapping scavenger (DcpS) enzymes catalyze the cleavage of a residual cap structure following 3' → 5' mRNA decay. Some previous studies suggested that both m(7)GpppG and m(7)GDP were substrates for DcpS hydrolysis. Herein, we show that mononucleoside diphosphates, m(7)GDP (7-methylguanosine diphosphate) and m(3)(2,2,7)GDP (2,2,7-trimethylguanosine diphosphate), resulting from mRNA decapping by the Dcp1/2 complex in the 5' → 3' mRNA decay, are not degraded by recombinant DcpS proteins (human, nematode, and yeast). Furthermore, whereas mononucleoside diphosphates (m(7)GDP and m(3)(2,2,7)GDP) are not hydrolyzed by DcpS, mononucleoside triphosphates (m(7)GTP and m(3)(2,2,7)GTP) are, demonstrating the importance of a triphosphate chain for DcpS hydrolytic activity. m(7)GTP and m(3)(2,2,7)GTP are cleaved at a slower rate than their corresponding dinucleotides (m(7)GpppG and m(3)(2,2,7)GpppG, respectively), indicating an involvement of the second nucleoside for efficient DcpS-mediated digestion. Although DcpS enzymes cannot hydrolyze m(7)GDP, they have a high binding affinity for m(7)GDP and m(7)GDP potently inhibits DcpS hydrolysis of m(7)GpppG, suggesting that m(7)GDP may function as an efficient DcpS inhibitor. Our data have important implications for the regulatory role of m(7)GDP in mRNA metabolic pathways due to its possible interactions with different cap-binding proteins, such as DcpS or eIF4E.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22985415      PMCID: PMC3495079          DOI: 10.1021/bi300781g

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  28 in total

1.  DcpS can act in the 5'-3' mRNA decay pathway in addition to the 3'-5' pathway.

Authors:  Erwin van Dijk; Hervé Le Hir; Bertrand Séraphin
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-01       Impact factor: 11.205

Review 2.  The enzymes and control of eukaryotic mRNA turnover.

Authors:  Roy Parker; Haiwei Song
Journal:  Nat Struct Mol Biol       Date:  2004-02       Impact factor: 15.369

3.  Human Dcp2: a catalytically active mRNA decapping enzyme located in specific cytoplasmic structures.

Authors:  Erwin van Dijk; Nicolas Cougot; Sylke Meyer; Sylvie Babajko; Elmar Wahle; Bertrand Séraphin
Journal:  EMBO J       Date:  2002-12-16       Impact factor: 11.598

4.  Functional link between the mammalian exosome and mRNA decapping.

Authors:  Z Wang; M Kiledjian
Journal:  Cell       Date:  2001-12-14       Impact factor: 41.582

Review 5.  Ascaris and ascariasis.

Authors:  D W Crompton
Journal:  Adv Parasitol       Date:  2001       Impact factor: 3.870

6.  Coordinate expression of NADPH-dependent flavin reductase, Fre-1, and Hint-related 7meGMP-directed hydrolase, DCS-1.

Authors:  Dorota A Kwasnicka; Agnieszka Krakowiak; Colin Thacker; Charles Brenner; Steven R Vincent
Journal:  J Biol Chem       Date:  2003-07-18       Impact factor: 5.157

7.  Biophysical studies of eIF4E cap-binding protein: recognition of mRNA 5' cap structure and synthetic fragments of eIF4G and 4E-BP1 proteins.

Authors:  Anna Niedzwiecka; Joseph Marcotrigiano; Janusz Stepinski; Marzena Jankowska-Anyszka; Aleksandra Wyslouch-Cieszynska; Michal Dadlez; Anne-Claude Gingras; Pawel Mak; Edward Darzynkiewicz; Nahum Sonenberg; Stephen K Burley; Ryszard Stolarski
Journal:  J Mol Biol       Date:  2002-06-07       Impact factor: 5.469

8.  Insights into the structure, mechanism, and regulation of scavenger mRNA decapping activity.

Authors:  Meigang Gu; Carme Fabrega; Shin-Wu Liu; Hudan Liu; Megerditch Kiledjian; Christopher D Lima
Journal:  Mol Cell       Date:  2004-04-09       Impact factor: 17.970

9.  The scavenger mRNA decapping enzyme DcpS is a member of the HIT family of pyrophosphatases.

Authors:  Hudan Liu; Nancy D Rodgers; Xinfu Jiao; Megerditch Kiledjian
Journal:  EMBO J       Date:  2002-09-02       Impact factor: 11.598

10.  A split active site couples cap recognition by Dcp2 to activation.

Authors:  Stephen N Floor; Brittnee N Jones; Gail A Hernandez; John D Gross
Journal:  Nat Struct Mol Biol       Date:  2010-08-15       Impact factor: 15.369

View more
  12 in total

1.  Synthesis, properties, and biological activity of boranophosphate analogs of the mRNA cap: versatile tools for manipulation of therapeutically relevant cap-dependent processes.

Authors:  Joanna Kowalska; Anna Wypijewska del Nogal; Zbigniew M Darzynkiewicz; Janina Buck; Corina Nicola; Andreas N Kuhn; Maciej Lukaszewicz; Joanna Zuberek; Malwina Strenkowska; Marcin Ziemniak; Maciej Maciejczyk; Elzbieta Bojarska; Robert E Rhoads; Edward Darzynkiewicz; Ugur Sahin; Jacek Jemielity
Journal:  Nucleic Acids Res       Date:  2014-08-22       Impact factor: 16.971

2.  mRNA cap analogues substituted in the tetraphosphate chain with CX2: identification of O-to-CCl2 as the first bridging modification that confers resistance to decapping without impairing translation.

Authors:  Anna M Rydzik; Marcin Warminski; Pawel J Sikorski; Marek R Baranowski; Sylwia Walczak; Joanna Kowalska; Joanna Zuberek; Maciej Lukaszewicz; Elzbieta Nowak; Timothy D W Claridge; Edward Darzynkiewicz; Marcin Nowotny; Jacek Jemielity
Journal:  Nucleic Acids Res       Date:  2017-09-06       Impact factor: 16.971

3.  Identification of Drosophila and human 7-methyl GMP-specific nucleotidases.

Authors:  Juliane Buschmann; Bodo Moritz; Mandy Jeske; Hauke Lilie; Angelika Schierhorn; Elmar Wahle
Journal:  J Biol Chem       Date:  2012-12-05       Impact factor: 5.157

4.  Multiple Nudix family proteins possess mRNA decapping activity.

Authors:  Man-Gen Song; Sophie Bail; Megerditch Kiledjian
Journal:  RNA       Date:  2013-01-25       Impact factor: 4.942

5.  Synthesis and evaluation of fluorescent cap analogues for mRNA labelling.

Authors:  Marcin Ziemniak; Mariusz Szabelski; Maciej Lukaszewicz; Anna Nowicka; Edward Darzynkiewicz; Robert E Rhoads; Zbigniew Wieczorek; Jacek Jemielity
Journal:  RSC Adv       Date:  2013       Impact factor: 3.361

6.  Loss of the scavenger mRNA decapping enzyme DCPS causes syndromic intellectual disability with neuromuscular defects.

Authors:  Calista K L Ng; Mohammad Shboul; Valerio Taverniti; Carine Bonnard; Hane Lee; Ascia Eskin; Stanley F Nelson; Mohammed Al-Raqad; Samah Altawalbeh; Bertrand Séraphin; Bruno Reversade
Journal:  Hum Mol Genet       Date:  2015-02-24       Impact factor: 6.150

7.  Elimination of cap structures generated by mRNA decay involves the new scavenger mRNA decapping enzyme Aph1/FHIT together with DcpS.

Authors:  Valerio Taverniti; Bertrand Séraphin
Journal:  Nucleic Acids Res       Date:  2014-11-28       Impact factor: 16.971

Review 8.  Applications of Phosphate Modification and Labeling to Study (m)RNA Caps.

Authors:  Marcin Warminski; Pawel J Sikorski; Joanna Kowalska; Jacek Jemielity
Journal:  Top Curr Chem (Cham)       Date:  2017-01-23

9.  Effect of the His-Tag Location on Decapping Scavenger Enzymes and Their Hydrolytic Activity toward Cap Analogs.

Authors:  Aleksandra Ferenc-Mrozek; Elzbieta Bojarska; Janusz Stepinski; Edward Darzynkiewicz; Maciej Lukaszewicz
Journal:  ACS Omega       Date:  2020-05-06

10.  An excess of catalytically required motions inhibits the scavenger decapping enzyme.

Authors:  Ancilla Neu; Ursula Neu; Anna-Lisa Fuchs; Benjamin Schlager; Remco Sprangers
Journal:  Nat Chem Biol       Date:  2015-08-10       Impact factor: 15.040

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.